ANGLE (ANPCF) Days Inventory : 463.47 (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is ANGLE Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). ANGLE's Average Total Inventories for the six months ended in Dec. 2024 was $2.12 Mil. ANGLE's Cost of Goods Sold for the six months ended in Dec. 2024 was $0.83 Mil. Hence, ANGLE's Days Inventory for the six months ended in Dec. 2024 was 463.47.

The historical rank and industry rank for ANGLE's Days Inventory or its related term are showing as below:

ANPCF' s Days Inventory Range Over the Past 10 Years
Min: 549.02 Med: 1504.72 Max: 1913.48
Current: 563.85

During the past 13 years, ANGLE's highest Days Inventory was 1913.48. The lowest was 549.02. And the median was 1504.72.

ANPCF's Days Inventory is ranked worse than
98.91% of 183 companies
in the Medical Diagnostics & Research industry
Industry Median: 72.87 vs ANPCF: 563.85

ANGLE's Days Inventory declined from Dec. 2023 (1,765.71) to Dec. 2024 (463.47).

Inventory Turnover measures how fast the company turns over its inventory within a year. ANGLE's Inventory Turnover for the six months ended in Dec. 2024 was 0.39.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. ANGLE's Inventory-to-Revenue for the six months ended in Dec. 2024 was 0.92.

ANGLE Days Inventory Historical Data

The historical data trend for ANGLE's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANGLE Days Inventory Chart

ANGLE Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Inventory

Get a 7-Day Free Trial

1,876.79

1,507.67

1,692.59

1,015.03

549.37

ANGLE Semi-Annual Data
	Apr15	Oct15	Apr16	Oct16	Apr17	Oct17	Apr18	Oct18	Apr19	Oct19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Days Inventory	Get a 7-Day Free Trial															1,295.64	851.45	1,765.71	738.97	463.47

Competitive Comparison of ANGLE's Days Inventory

For the Diagnostics & Research subindustry, ANGLE's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ANGLE's Days Inventory Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ANGLE's Days Inventory distribution charts can be found below:

* The bar in red indicates where ANGLE's Days Inventory falls into.

Save Embed

;

Save Embed

;

ANGLE Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

ANGLE's Days Inventory for the fiscal year that ended in Dec. 2024 is calculated as

	Days Inventory (A: Dec. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2023 )	+	Total Inventories (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (2.125	+	1.996)	/	2 )	/	1.369	*	365
=	2.0605					/	1.369	*	365
=	549.37

ANGLE's Days Inventory for the quarter that ended in Dec. 2024 is calculated as:

	Days Inventory (Q: Dec. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2024 )	+	Total Inventories (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (2.24	+	1.996)	/	2 )	/	0.834	*	365 / 2
=	2.118					/	0.834	*	365 / 2
=	463.47

ANGLE (OTCPK:ANPCF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

ANGLE's Inventory Turnover for the six months ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.834	/	2.118
	=	0.39

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

ANGLE's Inventory to Revenue for the six months ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	2.118	/	2.311
	=	0.92

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

ANGLE Days Inventory Related Terms

Thank you for viewing the detailed overview of ANGLE's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

ANGLE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ANGLE PLC (OTCPK:ANPCF) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

ANPCY:USA AGL:UK

Address

10 Nugent Road, The Surrey Research Park, Surrey, Guildford, GBR, GU2 7AF

Website

https://www.angleplc.com

ANGLE PLC is active in the healthcare sector in the United Kingdom. The Company's principal trading activity is undertaken in relation to the development and commercialization of the Parsortix cell separation system, with deployment in liquid biopsy that is non-invasive cancer diagnostics. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which the majority of its revenue is generated from Europe.